| Recruiting | Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostat NCT03880422 | Roswell Park Cancer Institute | N/A |
| Completed | Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer NCT03103321 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Collection of Serum Samples in Studying Emotional Stress in Patients With Prostate Cancer NCT03122743 | Wake Forest University Health Sciences | — |
| Terminated | sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer NCT02767921 | University of Southern California | Phase 1 |
| Completed | Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer NCT02163317 | Case Comprehensive Cancer Center | N/A |
| Completed | The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer NCT02250014 | University of Colorado, Denver | Phase 1 |
| Terminated | Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progr NCT02420652 | Rutgers, The State University of New Jersey | Phase 2 |
| Completed | Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery NCT02144649 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Sur NCT02446366 | University of Southern California | N/A |
| Completed | Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer NCT02048150 | City of Hope Medical Center | Phase 1 |
| Active Not Recruiting | High-Dose Brachytherapy in Treating Patients With Prostate Cancer NCT02346253 | Stanford University | N/A |
| Active Not Recruiting | Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer NCT02176902 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer NCT02217709 | University of Southern California | Phase 2 |
| Withdrawn | Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer NCT02179762 | Case Comprehensive Cancer Center | N/A |
| Completed | Diffuse Optical Imaging With Indocyanine Green Solution in Imaging Pelvic Lymph Nodes in Patients With Stage I NCT02119858 | City of Hope Medical Center | Phase 1 |
| Completed | A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine NCT01992016 | University of Colorado, Denver | N/A |
| Active Not Recruiting | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prosta NCT02023463 | Thomas Jefferson University | Phase 1 |
| Completed | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Under NCT01912820 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery NCT01923506 | City of Hope Medical Center | Phase 1 |
| Completed | Extended Cancer Education for Longer-Term Survivors in Primary Care for Patients With Stage I-II Breast or Pro NCT03233555 | Rutgers, The State University of New Jersey | N/A |
| Terminated | Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer NCT01928485 | Sanjay Gupta PhD | Phase 2 |
| Completed | Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery NCT02603965 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer NCT01731912 | University of Washington | N/A |
| Active Not Recruiting | Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing S NCT01823562 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer NCT01655836 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | High-Dose Stereotactic Radiation for Prostate Cancer NCT01664130 | Case Comprehensive Cancer Center | N/A |
| Terminated | Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated NCT01469338 | University of Southern California | Phase 2 |
| Withdrawn | Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer NCT01859689 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Withdrawn | Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivati NCT01555632 | University of Nebraska | N/A |
| Completed | Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer NCT01325311 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery NCT01433913 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients NCT01882985 | University of California, Irvine | Phase 2 |
| Completed | Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients NCT00956163 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Terminated | Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate NCT00937768 | Mayo Clinic | Phase 2 |
| Completed | Diffusion-Weighted MRI in Staging Patients With Localized Prostate Cancer NCT02237612 | University of Southern California | N/A |
| Completed | Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Locali NCT00589472 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy NCT01656304 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Terminated | Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery NCT01340599 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With NCT00108732 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer NCT00103194 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cilengitide in Treating Patients With Prostate Cancer NCT00121238 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Perifosine in Treating Patients With Recurrent Prostate Cancer NCT00058214 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer NCT00005067 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer NCT00003832 | National Cancer Institute (NCI) | Phase 2 |